Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hair analysis for stress and reproductive hormones in wildlife needs more research for accuracy across species.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Elagolix did not effectively treat polycystic ovary syndrome.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

PCOS treatment focuses on inducing ovulation, reducing androgens, and managing long-term health risks with medications and lifestyle changes.

Delayed puberty often runs in families, can affect growth, and may need hormone treatment.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Women with PCOS are more likely to have depression and anxiety.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.